0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Cardiovascular medicine

Buy Now

Implantable Defibrillator Therapy: A Clinical Guide (Paperback, Softcover reprint of the original 1st ed. 2002) Loot Price: R4,266
Discovery Miles 42 660
Implantable Defibrillator Therapy: A Clinical Guide (Paperback, Softcover reprint of the original 1st ed. 2002): Antonio...

Implantable Defibrillator Therapy: A Clinical Guide (Paperback, Softcover reprint of the original 1st ed. 2002)

Antonio Pacifico, Philip D. Henry, Gust H. Bardy, Martin Borggrefe, Francis E. Marchlinski, Andrea Natale, Bruce L. Wilkoff

Series: Developments in Cardiovascular Medicine, 244

 (sign in to rate)
Loot Price R4,266 Discovery Miles 42 660 | Repayment Terms: R400 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Implantable defibrillators as originally conceived by Michel Mirowski were limited to the detection and automatic termination of ventricular fibrillation. In the original "AID" device, the detection algoritlun sought to distinguish sinus rhytlun from ventricular fibrillation by identifying the "more sinusoidal waveform of ventricular fibrillation. " The therapeutic intervention was elicited only once deadly polymorphic rhythms had developed. It was rapidly learned, however, that ventricular fibrillation is usually preceded by ventricular tachycardia. Mirowski recognized the pivotal importance of developing algoritllms based on heart rate. Ventricular tachycardia detection allowed the successful development of interventions for the termination of ventricular tachyarrhythmias before they degenerated into ventricular fibrillation. Current device therapy no longer confines itself to tlle termination of chaotic rhythms but seeks to prevent them. Diagnostic algorithms moved upward along the chain of events leading to catastrophic rhytlulls. Rate smoothing algorithms were developed to prevent postextrasystolic pauses from triggering ventricular and atrial tachyarrhytlmlias. Beyond the renaissance of ectopy-centered strategies, long-term prevention received increasing attention. Multisite pacing therapies provided by "Arrhythmia Management Devices" were designed to reduce the "arrhytlunia burden" and optimize the synergy of cardiac contraction and relaxation. Clinical evidence now suggests that atrial fibrillation prevention by pacing is feasible and tllat biventricular pacing may be of benefit in selected patients with heart failure. However, these applications of device therapy that generally require ventricular defibrillation backup remain investigational and were not considered in this book.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Developments in Cardiovascular Medicine, 244
Release date: March 2013
First published: 2002
Authors: Antonio Pacifico • Philip D. Henry • Gust H. Bardy • Martin Borggrefe • Francis E. Marchlinski • Andrea Natale • Bruce L. Wilkoff
Dimensions: 235 x 155 x 21mm (L x W x T)
Format: Paperback
Pages: 410
Edition: Softcover reprint of the original 1st ed. 2002
ISBN-13: 978-1-4613-5372-0
Categories: Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
LSN: 1-4613-5372-6
Barcode: 9781461353720

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners